Company intelligence / Profile preview
Zhejiang Damao Pharmaceutical
- Ownership
- Private
- Development stage
- Phase 2
Overview
Damao Pharmaceutical is engaged in the marketing, trading, and distribution of a wide range of pharmaceutical formulation products. The company offers around 120 branded finished formulations, with manufacturing outsourced to third parties. It also trades active pharmaceutical ingredients (APIs). The product portfolio is diverse across multiple therapeutic segments, but no clinical-stage R&D or proprietary drug development has been reported.
- Modalities
- Small molecule (finished formulations)Active pharmaceutical ingredients (APIs)
- Industry
- Chemicals & Materials
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Zhejiang Damao Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhejiang Damao Pharmaceutical.